Related Experiment Video

Updated: Jun 27, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Psoriasis: an opportunity to identify cardiovascular risk

D G Federman1, M Shelling, S Prodanovich

  • 1Department of Medicine, VA Connecticut Health Care Center (11ACSL), 950 Campbell Ave., West Haven, CT 06516, USA. daniel.federman@va.gov

The British Journal of Dermatology
|November 20, 2008
PubMed

Insights

Psoriasis patients face higher risks of cardiovascular issues, including heart attacks and mortality. Early evaluation and treatment of cardiovascular risk factors are crucial for managing psoriasis patients

Area of Science:

  • Dermatology
  • Cardiology
  • Immunology

Background:

  • Psoriasis is a prevalent inflammatory skin condition linked to systemic comorbidities.
  • Patients with psoriasis exhibit a higher prevalence of cardiovascular risk factors.
  • Severe psoriasis is associated with increased risks of myocardial infarction and mortality.

Purpose of the Study:

  • To review the association between psoriasis, atherosclerosis, and inflammation.
  • To highlight treatable cardiovascular risk factors in psoriasis patients.
  • To emphasize the importance of cardiovascular risk assessment and management in psoriasis care.

Main Methods:

  • Literature review on psoriasis, cardiovascular disease, and inflammation.
  • Analysis of epidemiological data and clinical studies.
  • Synthesis of current understanding of shared pathophysiological mechanisms.

Main Results:

  • Psoriasis is significantly associated with increased cardiovascular risk factors.
  • Inflammation plays a key role in the link between psoriasis and atherosclerosis.
  • Treatable risk factors can potentially mitigate cardiovascular risk in psoriasis.

Conclusions:

  • Dermatologists must be aware of the cardiovascular risks in psoriasis patients.
  • Comprehensive evaluation and management of cardiovascular risk factors are essential.
  • Addressing cardiovascular health can improve outcomes for individuals with psoriasis.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...